Monoamine oxidase inhibitors I-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity

British Journal of Cancer

Volumn 89, Issue 10, 2003, Pages 1979-1986

  Seymour, C B ^a,b   Mothersill, C ^a,b,d   Mooney, R ^a   Moriarty, M ^b   Tipton, K F ^c  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b St Luke's Inst for Cancer Research   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Apoptosis; Clorgyline; I deprenyl; Monoamine oxidase inhibitors (MAOIs); Radiation protection

Indexed keywords

CISPLATIN; CLORGYLINE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; PARGYLINE; PROTEIN BCL 2; SELEGILINE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; COBALT THERAPY; CONTROLLED STUDY; DRUG MECHANISM; GAMMA RADIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; NEUROPROTECTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CLORGYLINE; GAMMA RAYS; HUMANS; MICE; MONOAMINE OXIDASE INHIBITORS; RADIATION-PROTECTIVE AGENTS; SELEGILINE; TUMOR CELLS, CULTURED; URINARY BLADDER;

EID: 0346121830     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601361     Document Type: Article

References (35)

1. Birkmayer W, Riederer P, Youdim M, Linauer W (1975) Potentiation of the anti-akinetic effect of L-dopa treatment by an inhibitor of MAO-B, deprenyl. J Neural Transmission 36: 303-326
2. Boukamp P, Popp S, Bleuel K, Tomakidi E, Burkle A, Fusenig NE (1999) Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene 18(41): 5638-5645
3. Chiueh CC, Huang SJ, Murphy DL (1994) Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity. J Neural Transmission 41(Suppl): 189-196
4. Finberg J, Lamensdorf I, Weinstock M, Schwartz M, Youdim MBH (1999) Pharmacology of rasagiline (N-propargyl-1R-aminoindan). Adv Neurol 80: 495-499
5. Hockenbery DM, Nunez G, Milliman C, Schrieber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-335
6. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CJ, Korsmeyer SJ (1993) BCL-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell 75: 241-243
7. Huang W, Chen Y, Shohami W, Weinstock M (1999) Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse. Eur J Pharmacol 366: 127-135
8. Itoh N, Tsujimoto Y, Nagata S (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151: 621-627
9. Kragten E, Lalande I, Zimmermann K, Roggo S, Schindler P, Müller D, Oostrum J, Waldmeier P, Fürst P (1998) Glyceraldehyde 3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-) deprenyl. J Biol Chem 273: 5821-5828
10. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993 Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53(19): 4701-4714
11. Li XM, Juorio AV, Paterson IA, Zhu MY, Boulton AA (1992) Specific irreversible monoamine oxidase-B inhibitors stimulate gene expression of aromatic 1-amino acid decarboxylase in PC12 cells. J Neurochem 59: 2324-2327
12. Lyng FM, Seymour CB, Mothersill C (2002) Initiation of apoptosis in cells exposed to medium from the progeny of irradiated cells: a possible mechanism for 'bystander' induced instability. Radiat Res 157: 365-370
13. Maruyama W, Boulton AA, Davis BA, Dostert P, Naoi M (2001) Enantiospecific induction of apoptosis by an endogenous neurotoxin, N-methyl(R) salolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine. J Neural Transmission 108: 11-24
14. Mothersill C, Cusack A, Seymour CB (1988) Radiation induced outgrowth inhibition in explant cultures from surgical specimens of five human organs. Br J Radiol 61: 226-230
15. Mothersill C, Harney F, Lyng F, Cottell D, Seymour C (1995) Primary explants of normal uroepithelium show an unusual response to low doses of Cobalt-60 gamma rays. Radiat Res 142: 177-183
16. Mothersill C, Seymour CB (2001) Radiation-induced bystander effects: past history and future directions. Radiat Res 155(6): 759-767
17. Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han S-K, Werner P, Cohen G, Olanow W (1997) Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J Pharmacol Exp Therap 284: 700-706
18. O'Brien EM, Tipton KF (1994) Biochemistry and mechanism of action of monoamine oxidases A and B. In Monoamine Oxidase Inhibitors in Neurological Diseases, Lieberman A, Olanow CW, Youdim MBH, Tipton KF (eds) pp 31-76. New York: Marcel-Dekker
19. Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaolo JA (1987) Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1(4): 1061-1066
20. Puck TT, Marcus I (1956) Action of X-rays on mammalian cells. J Exp Med 103: 653-666
21. Salo PT, Tatton WG (1991) Deprenyl reduces the death of motorneurons caused by axotomy. J Neurosci Res 31: 394-400
22. 2+ efflux. Biochim Biophys Acta 1035: 300-305
23. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) BCL-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888
24. Seymour CB, Mothersill C, Alper T (1986) High yields of lethal mutations in somatic cells that survive ionizing radiation. Int J Radiat Biol 50: 167-179
25. Shih JC (1991) Molecular basis of human MAO-A and MAO-B. Neuropsychopharmacology 4: 1-7
26. Shimazu S, Tanigawa A, Sato N, Yoneda F, Hayashi K, Knoll J (2003) Enhancer Substances: Selegiline and R-(-)-1-(benzofuran-2-yl)-2- propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes. Life Sci 72: 2785-2792
27. Tatton WG, Chalmers-Redman RME, Ju WYH, Mammen M, Carlile GW, Pong AW, Tatton NA (2002) Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Therap 301: 753-764
28. Tatton WG, Greenwood CE (1991) Rescue of dying neurons: a new action for deprenyl in MPTP Parkinsonism. J Neurosci Res 30: 666-672
29. Tatton WG, Ju WYL, Holland DP, Tai C, Kwan M (1994a) Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 63: 1572-1575
30. Tatton WG, Seniuk NA, Ju WYH, Ansari KS (1994b) Reduction of nerve cell death by deprenyl without monoamine oxidase inhibition. In Monoamine Oxidase Inhibitors in Neurological Diseases, Lieberman A, Olanow CW, Youdim MBH, Tipton KF (eds) pp 217-248. New York: Marcel-Dekker
31. Thiffault C, Aumont N, Quirion R, Poirier J (1995) Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J Neurochem 65: 2725-2733
32. Wadia JS, Chalmers-Redman RME, Ju WJH, Carlile GW, Phillips JL, Fraser AD, Tatton WG (1998) Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl. J Neurosci 18: 932-947
33. Yu PH (1986) Monoamine oxidase. In Neuromethods. Neurotransmitter Enzymes, Boulton AA, Baker GB, Yu PH (eds) Vol. V pp 235-272. Clifton, NJ: Humana Press
34. Zhang D, Berry MD, Paterson IA, Boulton AA (1999) Loss of mitochondrial membrane potential is dependent on the apoptotic program activated: prevention by R-2HMP. J Neurosci Res 58: 284-292
35. Zhong LT, Sarafian T, Kane DJ, Charles AG, Mah SP, Edwards RH, Bredesen DE (1993) bcl-2 inhibits death of central neural cells induced by multiple agents, 1993. Proc Natl Acad Sci USA 90: 4533-4537